Advanced Micro Devices (AMD) has the highest social signal in the last day. Value Stock members continue to hold this stock, accumulating it on the dip. BlackBerry (BBRY) barely spent a second below $10 before snapping back. The market now views BBRY as a software security firm with growth in IoT, automotive, and enterprise mobility. KeyOne is still an outlier, At least 1M business users will demand DTEK60 or KeyOne. Nvidia (NVDA) soared to new highs. The company over-delivered on earnings. Revenue SOARED 48% Y/Y. Net income, albeit non-GAAP rose an AMAZING 85%. Bernstein analysts upgraded the stock, citing machine learning and developments for self-driving cars as positive catalysts. NVDA is trading ex-dividend. Himax Technologies (HIMX) is about to retake $7.00 again. Next week is its week. Below: Facebook Oculus In biotech, Dynavax (DVAX) is still underperforming. DVAX lost $0.60 per share in Q1. Kerx Biopharma (KERX) spiked above $7.00. That was the exit price. Retake the stock in the $5.50 - $5.75 per share range. Synergy Pharma (SGYP) is in the dog house. Markets are highly bearish, betting against it with a 34% short float. Generic drug supplier Teva Pharmaceuticals (TEVA) broke below the all-critical $30 support. The company reported strong quarterly results but worries persist. As usual, the red-flag stocks investors should avoid include obesity drug supplier Arena Pharmaceuticals (ARNA), Novavax (NVAX). Amarin Corp. (AMRN) is not in this pile. When selling pressure drops, the stock may rebound. In Q1, AMRN reported revenue of $34.6M, up ~ 36% Y/Y. It lost $20.9M. AMRN forecast net product revenue in the range of $155M - $165M.